Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL5498077 | 0.96 | KDM4E (0.40) | — | |
| Hydrochloric Acid SCHEMBL15916954 | 0.96 | — | — | |
| SCHEMBL239012 | 0.95 | — | — | |
| Water SCHEMBL5381081 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL905740 | 0.91 | — | — | |
| Bromide SCHEMBL4656309 | 0.82 | — | — | |
| Bromide SCHEMBL27986213 | 0.78 | — | — | |
| SCHEMBL1978899 | 0.76 | — | — | |
| Phosphoric Acid SCHEMBL9111653 | 0.73 | BBOX1 (0.34) | — | |
| Phosphoric Acid SCHEMBL4080901 | 0.73 | SLC34A1 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023076902-A1 | POEGMA-BASED LIPID NANOPARTICLES | DUKE UNIVERSITY (US) | 2023-05-04 | — | — | WO | claimed |
| CN-102781428-B | Method and apparatus for preparing novel liposomes | 有限公司公元前世界医药 | 2017-09-19 | — | — | CN | claimed |
| CN-103857484-B | The method preparing hollow metal nanometer particle and the hollow metal nanometer particle prepared by the method | LG化学株式会社 | 2016-06-08 | — | — | CN | claimed |
| CN-104884198-A | Method for manufacturing hollow metal nanoparticle supported by support body | LG CHEMICAL LTD | 2015-09-02 | — | — | CN | claimed |
| CN-101879140-A | The nanoparticle and the sustained release compositions that comprise aryl-heterocyclic compounds | ELAN PHARMA INT LTD | 2010-11-10 | — | — | CN | claimed |
| CN-101495096-A | Nanoparticulate posaconazole formulations | ELAN PHARMA INT LTD (IE) | 2009-07-29 | — | — | CN | claimed |
| EP-1651189-B1 | NOVEL METAXALONE COMPOSITIONS | ELAN PHARMA INT LTD (IE) | 2008-12-03 | — | — | EP | claimed |
| CN-101287453-A | Nanoparticulate and controlled release compositions comprising a cephalosporin | ELAN PHARMA INT LTD (IE) | 2008-10-15 | — | — | CN | claimed |
| CN-101287451-A | Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor | ELAN PHARMA INT LTD (IE) | 2008-10-15 | — | — | CN | claimed |
| CN-101242813-A | Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds | ELAN PHARMA INT LTD (IE) | 2008-08-13 | — | — | CN | claimed |
| CN-101237868-A | Nanoparticulate clopidogrel and aspirin combination formulations | ELAN PHARMA INT LTD (IE) | 2008-08-06 | — | — | CN | claimed |
| CN-101212954-A | Nanoparticulate clopidogrel formulations | ELAN PHARMA INT LTD (IE) | 2008-07-02 | — | — | CN | claimed |
| EP-1658053-B1 | NOVEL COMPOSITIONS OF SILDENAFIL FREE BASE | ELAN PHARMA INT LTD (IE) | 2008-02-27 | — | — | EP | claimed |
| EP-1109926-A1 | CONDENSED PLASMID-LIPOSOME COMPLEX FOR TRANSFECTION | ALZA CORPORATION (US) | 2001-06-27 | — | — | EP | claimed |
| WO-2000015825-A1 | CONDENSED PLASMID-LIPOSOME COMPLEX FOR TRANSFECTION | ALZA CORPORATION (US) | 2000-03-23 | — | — | WO | claimed |
| US-20260115280-A1 | VACCINES | ADJUVANCE TECH INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260115281-A1 | TRITERPENE SAPONIN ANALOGUES | ADJUVANCE TECH INC (US) | 2026-04-30 | — | — | US | disclosed |
| EP-1017365-A1 | LIPOSOME-ENTRAPPED POLYNUCLEOTIDE COMPOSITION AND METHOD | SEQUUS PHARMACEUTICALS, INC. (US) | 2000-07-12 | — | — | EP | disclosed |
| WO-1998058630-A1 | LIPOSOME-ENTRAPPED POLYNUCLEOTIDE COMPOSITION AND METHOD | SEQUUS PHARMACEUTICALS, INC. (US) | 1998-12-30 | — | — | WO | disclosed |
| US-4314808-A | HAIR DYES; POLYASPARTIC ACID MODIFIED BY A DYE RESIDUE-CONTAINING AMINE; ANTISOILANTS | L'OREAL (FR) | 1982-02-09 | — | — | US | disclosed |